Biosimilars: An effective treatment at a lower cost

Biosimilars: An effective treatment at a lower cost

While most medications are both safe and effective, unfortunately many are also expensive. Biosimilars – new versions of a drug that are similar to the original in every meaningful way – offer a potentially less expensive alternative to costly original biological drugs. Professor Tore K. Kvien of the University of Oslo, Norway, and his colleagues have demonstrated that one biosimilar, […]

Read More…

A novel therapy could help patients with active Crohn’s disease

Dr Jahnsen's study aims to improve symptoms experienced by patients with Crohn’s disease, such as abdominal pain.

Professor Jørgen Jahnsen and PhD student Kristian Espeland of Akershus University Hospital and University of Oslo are responsible for a new clinical trial which aims to improve symptoms and control the inflammation of Crohn’s disease using Gliolan medication in combination with blue-light photopheresis. This approach will selectively cause the death of pro-inflammatory cells which contribute to the inflammatory bowel disease, […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at audience@researchoutreach.org at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION